在印度的MSM中对每日和长期作用的暴露前预防 (PrEP) 的看法和经验
Harsh Agarwal1, Ivania Núñez1, Lauren M Hill1
1Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
PLOS global public health
|January 17, 2024
概括
与男性发生性关系的印度男性 (MSM) 以高艾滋病毒风险为动机,有效地使用口服预暴露预防 (PrEP). 每日口服PrEP的坚持率很高,但长效注射PrEP是受欢迎的,成本和获取是关键考虑因素.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 社会科学 社会科学 社会科学
背景情况:
- 口服暴露前预防 (PrEP) 是一种高效的艾滋病毒预防方法.
- 在与男性发生性关系的印度男性 (MSM) 中,使用PrEP的意愿增加.
- 在这个人群中对口服和长效 (LA) 注射PrEP的现实体验,激励因素和障碍的理解有限.
研究的目的:
- 探索风险印度MSM中口服和LA注射PrEP使用的经验,激励因素,促进因素和障碍.
- 了解关于从口服转向LA注射PrEP的决策过程.
主要方法:
- 质量研究涉及通过社交媒体招募的18名MSM进行半结构面试.
- 采访的重点是关于PrEP的知识,获取,坚持,安全性行为的做法,障碍,促进者以及对LA PrEP的看法.
- 对编码的采访成绩单进行专题数据分析.
主要成果:
- 高感知艾滋病毒风险促使口服PrEP吸收.
- 主要通过免费或补贴服务的非营利组织获得PrEP.
- 参与者报告了很高的坚持,但对每日剂量表示不满;注意到对LA PrEP的偏好.
- 对于更广泛的PrEP可访问性,成本和可负担性是主要问题.
- LA注射PrEP受到欢迎,成本和可用性是转换的关键因素.
结论:
- 印度MSM使用口服PrEP与避孕套一起,通过各种道访问它.
- 对于广泛采用PrEP而言,成本和可访问性仍然是关键挑战.
- 在印度MSM背景下对LA PrEP可接受性的进一步研究至关重要.
- 政府的干预措施应优先考虑高风险群体的口服PrEP.
相关概念视频
01:19Pharmacovigilance
835
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:24Factors Influencing Drug Absorption: Presystemic Elimination
222
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
222